My academic papers (2018-2019)
• Qun Luo, Shengbo Liu, Liming Xie, Yongjie Yu, Limin Zhou, De Cai, Yuzhen Feng. (2019). Resveratrol ameliorates glucocorticoid-induced bone damage in a zebrafish model. Front Pharmacol. 2019 Mar 22;10:195. (IF: 3.845; * 为共同第一作者) Click to article
• Hui-Zhi Yang, Jiaojiao Zhang, Jie Zeng, Shengbo Liu, Fei Zhou, Fang Zhang, RongYi Chen & Maurizio Battino. (2019). Resveratrol inhibits the proliferation of melanoma cells by modulating cell cycle. International Journal of Food Sciences and Nutrition, 1–10. (IF: 2.792) Click to article
• Yunfang Yu, Dongqiang Zeng, Qiyun Ou, Shengbo Liu, Anlin Li, Yongjian Chen … Herui Yao. (2019). Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non–Small Cell Lung Cancer. JAMA Network Open, 2(7), e196879. Click to article
• 阳慧芝, 周飞, 刘盛波, 刘双, 谭卉卉, 张方, 陈嵘祎. (2018). 雌二醇对 Hela 细胞淋球菌感染模型il-6、il-8、nlrp3表达的影响. [J]. 广东医科大学报,Vol.36,No.1,Feb.2018. Click to article
Yunfang Yu, Ying Wang, Shengbo Liu, et al. Role of immune checkpoint inhibitor, tumor vaccine and cellular immunotherapy in advanced non-small-cell lung cancer. Journal of Clinical Oncology, 36, 2018; (Suppl; abstr. e21056). (ASCO Meeting Abstract; Published in Journal of Clinical Oncology; IF: 28.245) Click to article
• Ying Wang, Yunfang Yu, Shengbo Liu, Qiyun Ou, Herui Yao. Cyclin-dependent kinases 4 and 6 inhibitors in HR+ HER2- advanced breast cancer. Journal of Clinical Oncology, 36, 2018 (suppl; abstr e13048). (ASCO Meeting Abstract; Published in Journal of Clinical Oncology; IF: 28.245) Click to article
